Literature DB >> 20973916

Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients.

A Goh1, A Vathsala.   

Abstract

Urinary tract cancers are the third most common cancers in renal transplant recipients (RTX). This study examined the impact of dialysis duration and native renal cyst(s) (NRC) on renal cell carcinoma (RCC) occurrence among 1036 RTX followed-up from 1995 to July 2007. Abdominal ultrasonography was planned within 1-month of transplant, then every 5 years, or 2 years if renal cysts developed. Based on presence and time of development of NRC, RTX were grouped into those with no (No-NRC), new (New-NRC), preexisting (Pre-NRC) and time-indeterminate NRC (TI-NRC). Ten asymptomatic RTX were diagnosed with RCC at a median of 5.8 years posttransplant and had 5-year graft and patient survivals of 90% and 100%, respectively, following appropriate therapy. RCC occurred only in Pre-NRC and TI-NRC who had significantly longer dialysis duration than No- or New-NRC (6.7 ± 3.9 and 3.3 ± 3.2 vs. 2.7 ± 3.1 and 2.6 ± 2.4 years, respectively). These results suggest that NRC and increased dialysis duration are risk factors for RCC posttransplant. Since early treatment of RCC gives excellent outcomes, regular ultrasonography performed within a month of transplantation, then every 5 years for those without cysts and every 2 years for those with cysts for early detection of RCC is recommended. ©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2010        PMID: 20973916     DOI: 10.1111/j.1600-6143.2010.03303.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Native renal cysts linked to RCC in transplanted kidneys.

Authors:  Helene Myrvang
Journal:  Nat Rev Nephrol       Date:  2011-03       Impact factor: 28.314

Review 2.  Risk of chronic kidney disease after cancer nephrectomy.

Authors:  Lin Li; Wei Ling Lau; Connie M Rhee; Kevin Harley; Csaba P Kovesdy; John J Sim; Steve Jacobsen; Anthony Chang; Jaime Landman; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

3.  Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience.

Authors:  Su Hooi Teo; Kian-Guan Lee; Gek Hsiang Lim; Si Xuan Koo; Maria Erika Ramirez; Khuan Yew Chow; Terence Kee
Journal:  Singapore Med J       Date:  2018-10-10       Impact factor: 1.858

Review 4.  Urological Cancers and Kidney Transplantation: a Literature Review.

Authors:  Cristian Axel Hernández-Gaytán; Francisco Rodríguez-Covarrubias; Ricardo A Castillejos-Molina; Andrés Hernández-Porras; Ignacio Tobia; Justin M Dubin; Ana María Autrán-Gómez
Journal:  Curr Urol Rep       Date:  2021-12-16       Impact factor: 3.092

5.  Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report.

Authors:  Matteo Paoletti; Barbara Cattadori; Marilena Gregorini; Alessandra Viglio; Giovanni Gentile; Andrea Maria D'Armini; Carlo Pellegrini; Alfredo La Fianza
Journal:  CEN Case Rep       Date:  2018-01-31

6.  Renal cell cancer after kidney transplantation.

Authors:  Dennis Kleine-Döpke; Matthias Oelke; Anke Schwarz; Ysabell Schwager; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2018-07-12       Impact factor: 3.445

7.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

8.  Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

Authors:  S Karami; E L Yanik; L E Moore; R M Pfeiffer; G Copeland; L Gonsalves; B Y Hernandez; C F Lynch; K Pawlish; E A Engels
Journal:  Am J Transplant       Date:  2016-06-23       Impact factor: 9.369

Review 9.  Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.

Authors:  Chi Yuen Cheung; Man Fai Lam; King Chung Lee; Gavin Sheung Wai Chan; Kwok Wah Chan; Ka Foon Chau; Chun Sang Li; Tak Mao Chan; Kar Neng Lai
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

10.  Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney.

Authors:  In O Sun; Yu Mi Ko; Eun Young Kim; Kyung Seon Park; Hong Soon Jung; Sun Hye Ko; Byung Ha Chung; Bum Soon Choi; Cheol Whee Park; Yong Soo Kim; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.